Literature DB >> 2323477

Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management.

S S Hayreh1.   

Abstract

Anterior ischaemic optic neuropathy (AION), a common, visually crippling disorder, is discussed, with particular emphasis on differentiating AION due to giant cell arteritis (arteritic AION) from that not due to it (non-arteritic AION). Giant cell arteritis is an ophthalmic emergency because of imminent danger of bilateral total blindness, which is almost always preventable if the disease is quickly identified and treated urgently and aggressively. My studies have revealed that the best means of differentiating arteritic from non-arteritic AION is a combination of information from the following: systemic and visual symptoms of giant cell arteritis, high erythrocyte sedimentation rate and C-reactive protein, early massive visual loss, chalky-white optic disc swelling, associated cilio-retinal artery occlusion, massive non-filling of the choroid on fluorescein fundus angiography and temporal artery biopsy. Management of giant cell arteritis and of arteritic AION is discussed. Current misconceptions about AION are pointed out.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323477     DOI: 10.1038/eye.1990.4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  31 in total

1.  Non-arteritic anterior ischemic optic neuropathy versus cerebral ischemic stroke.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-21       Impact factor: 3.117

2.  Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?

Authors:  G P Brittain; G G McIlwaine; J A Bell; J M Gibson
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

3.  Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy.

Authors:  Corina Radoi; Tony Garcia; Catherine Brugniart; Alain Ducasse; Carl Arndt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-01       Impact factor: 3.117

Review 4.  Ocular vascular occlusive disorders: natural history of visual outcome.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2014-04-21       Impact factor: 21.198

5.  Transient visual loss due to reversible 'pending' central retinal artery occlusion in occult giant cell arteritis.

Authors:  M Sane; A Selvadurai; J Reidy; D Higgs; F Gonzalez-Fernandez; N Lincoff
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

6.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

7.  Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy.

Authors:  M Kaup; N Plange; K O Arend; A Remky
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

Review 8.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 9.  Surgery for nonarteritic anterior ischemic optic neuropathy.

Authors:  Kay Dickersin; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-03-12

10.  Familial non-arteritic anterior ischemic optic neuropathy.

Authors:  Sohan Singh Hayreh; John H Fingert; Edwin Stone; Daniel M Jacobson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.